RxDoctor Payments DataLook up a doctor →

ONGENTYS: payments to doctors

Payments that named ONGENTYS as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3M
Providers
7,958
Transactions
46,256
Average per transaction
$64

The per-transaction average — $64 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 7,958 providers the average total is $374, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Neurocrine Biosciences, Inc.$2,568,41086.3%
Amneal Pharmaceuticals LLC$406,88113.7%
← All drugs & devices